June 09, 2020 article Viltolarsen: First Approval Drugs DOI: 10.1007/s40265-020-01339-3 OpenAlex Authors 0 Author list not loaded yet. Cited by 12 stored of 218 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Evaluating exon skipping in the central nervous system in Duchenne muscular dystrophy using spatial transcriptomics 2026 iScience article Biochemistry, Genetics and Molecular Biology Muscle Physiology and Disorders Open access 0 citations Antisense-mediated exon skipping therapy improves neuromuscular junction deficits in a Duchenne muscular dystrophy mouse model 2025 Neuromuscular Disorders article Biochemistry, Genetics and Molecular Biology Muscle Physiology and Disorders Open access 1 citations ExonViz: A user friendly application to visualize transcripts and genetic variants 2024 medRxiv preprint Biochemistry, Genetics and Molecular Biology Genomics and Rare Diseases Open access 0 citations Nucleic acid degradation as barrier to gene delivery: a guide to understand and overcome nuclease activity 2023 Chemical Society Reviews review Biochemistry, Genetics and Molecular Biology RNA Interference and Gene Delivery cited by 1 patent 129 citations Challenges of Assessing Exon 53 Skipping of the Human DMD Transcript with Locked Nucleic Acid-Modified Antisense Oligonucleotides in a Mouse Model for Duchenne Muscular Dystrophy 2023 Nucleic Acid Therapeutics article Biochemistry, Genetics and Molecular Biology Muscle Physiology and Disorders Open access cited by 1 patent 16 citations 269th ENMC international workshop: 10 years of clinical trials in Duchenne muscular dystrophy – What have we learned? 9–11 December 2022, Hoofddorp, The Netherlands 2023 Neuromuscular Disorders article Biochemistry, Genetics and Molecular Biology Muscle Physiology and Disorders Open access 6 citations Cardiovascular complications of diabetes: role of non-coding RNAs in the crosstalk between immune and cardiovascular systems 2023 Cardiovascular Diabetology article Biochemistry, Genetics and Molecular Biology MicroRNA in disease regulation Open access 32 citations Next steps for the optimization of exon therapy for Duchenne muscular dystrophy 2023 Expert Opinion on Biological Therapy article Biochemistry, Genetics and Molecular Biology Muscle Physiology and Disorders Open access cited by 2 patents 22 citations Low human dystrophin levels prevent cardiac electrophysiological and structural remodelling in a Duchenne mouse model 2021 Scientific Reports article Medicine Cardiac electrophysiology and arrhythmias Open access 15 citations Delivery of oligonucleotide‐based therapeutics: challenges and opportunities 2021 EMBO Molecular Medicine article Biochemistry, Genetics and Molecular Biology RNA Interference and Gene Delivery Open access cited by 13 patents 388 citations Detailed genetic and functional analysis of the hDMDdel52/mdx mouse model 2020 PLoS ONE article Biochemistry, Genetics and Molecular Biology Muscle Physiology and Disorders Open access cited by 1 patent 30 citations Developments in reading frame restoring therapy approaches for Duchenne muscular dystrophy 2020 Expert Opinion on Biological Therapy article Biochemistry, Genetics and Molecular Biology Muscle Physiology and Disorders Open access 25 citations 12 results References 0